Press Releases

Date	Title	File/s
Dec 06, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 13, 2024	Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Nov 06, 2024	Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
Nov 01, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 22, 2024	Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Oct 04, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 26, 2024	Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress
Sep 06, 2024	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 12, 2024	Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Aug 05, 2024	Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12